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Introduction: In recent years, with increased prevalence of viral infections and 
having no specific treatment  and also the continuous appearance of resistant viral 
strains, finding of novel antiviral agents is necessary. 
 
Methods and Results: In this study, monoterpenes of thymol, carvacrol and p-
cymene were screened for their inhibitory effect against herpes simplex virus type 1 
(HSV-1) in vitro on Vero cell line CCL-81-ATCC using a plaque reduction assay. 
The antiviral activity of three monoterpenes (thymol, carvacrol and p-cymene) were 
evaluated by cytotoxicity assay, direct plaque test. In addition, the modes of antiviral 
action of these compounds were investigated during the viral infection cycle. Results 
showed that the inhibitory concentrations (IC50) were determined at 0.002%, 0.037% 
and >0.1%, for thymol, carvacrol, p-cymene, respectively. A manifestly dose-
dependent virucidal activity against HSV-1 could be exhibited for compounds tested. 
In order to determine the mode of the inhibitory effect, compounds were added at 
different stages during the viral infection cycle. At maximum non-cytotoxic 
concentrations of the compounds, plaque formation was significantly reduced by 
more than 80% when HSV-1 was pre incubated with p-cymene. However, no 
inhibitory effect could be observed when the compounds were added to the cells 
prior to infection with HSV-1 or after the adsorption period. 
 
Conclusions: 
These results indicate that compounds affected HSV-1 mostly before adsorption and 
might interact with the viral envelope. Thymol exhibited a high selectivity index and 
seems to be a promising candidate for topical therapeutic application as antiviral 
agent for treatment of herpetic infections.  
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